Michelle R. Pereira

270 Joondalup Drive
Joondalup, WA 6027, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Detection of metastases using circulating tumour DNA in uveal melanoma.

Detection of metastases using circulating tumour DNA in uveal melanoma.

Journal: Journal of cancer research and clinical oncology

Published: June 13, 2023

Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.

Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.

Journal: Cancers

Published: November 07, 2021

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.

Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression.

Journal: British journal of cancer

Published: March 08, 2021

The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant Detection.

The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant Detection.

Journal: Cancers

Published: November 07, 2020

Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression.

Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression.

Journal: Cancers

Published: October 21, 2020

Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies.

Detection of BRAF splicing variants in plasma-derived cell-free nucleic acids and extracellular vesicles of melanoma patients failing targeted therapy therapies.

Journal: Oncotarget

Published: August 07, 2020

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.

Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 10, 2020

A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma.

A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma.

Journal: Scientific reports

Published: October 11, 2019

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies.

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies.

Journal: Oncotarget

Published: June 24, 2018

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma.

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma.

Journal: Molecular oncology

Published: June 20, 2018

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma.

Journal: JCO precision oncology

Published: May 17, 2018

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

Journal: BMC cancer

Published: February 23, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026